Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b

Fifty-one polycythemia vera (PV) patients were enrolled in the phase I/II clinical study PEGINVERA to receive a new formulation of pegylated interferon alpha (peg-proline-IFNα-2b, AOP2014/P1101). Peg-proline-IFNα-2b treatment led to high response rates on both hematologic and molecular levels. Hemat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Hematol
Glavni autori: Them, Nicole CC, Bagienski, Klaudia, Berg, Tiina, Gisslinger, Bettina, Schalling, Martin, Chen, Doris, Buxhofer-Ausch, Veronika, Thaler, Josef, Schloegl, Ernst, Gastl, Guenther A, Wolf, Dominik, Strecker, Karin, Egle, Alexander, Melchardt, Thomas, Burgstaller, Sonja, Willenbacher, Ella, Zagrijtschuk, Oleh, Klade, Christoph, Greil, Richard, Gisslinger, Heinz, Kralovics, Robert
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2015
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4657499/
https://ncbi.nlm.nih.gov/pubmed/25545244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23928
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items